Abstract:A series of new 5-alkyl-2-phenylaminocarbonylmethylthiopyrimidin-4(3H)-ones bearing variously substituted arylmethyl moieties at the C6 position of the pyrimidine ring were synthesized and evaluated for anti-HIV activity in MT-4 cells. Most of these new congeners exhibited moderate to good activities against the wild-type virus, with EC(50) values in the range of 1.40-0.19 mu m. Among them, 2-[(4-cyanophenylamino)carbonylmethylthio]- 6-(2-chloro-6-fluorobenzyl)-5-ethylpyrimidin-4(3H)-one 4b6 is one of the compounds endowed with the highest broad-spectrum HIV-1 inhibitory activity, with EC(50) values of .19 +/- 0.005 mu m against the wild-type virus, 1.05 +/- 0.24 mu m (twofold resistance) against the E138K strain, and 2.38 +/- 0.13 mu m (4.5-fold resistance) against the Y181C strain. Furthermore, reverse transcriptase (RT) inhibition assays against wildtype HIV-1 RT were performed with selected derivatives, confirming that the main target of these compounds is HIV-1 RT and that these new S-DABO analogues act as non-nucleoside RT inhibitors (NNRTIs). Structure-activity relationship and molecular modeling analyses of these new congeners are also discussed.

Regioselective Synthesis of the Novel N4‐Substituted Pyrazolo[4,5‐e][1,2,4]thiadiazines As Potent HIV‐1 NNRTIs.

Regioselective Synthesis of the Novel N4-Substituted Pyrazolo[4,5-e][1,2,4]thiadiazines As Potent HIV-1 NNRTIs

Regioselective Synthesis and Anti-Hiv Activity of the Novel 2- and 4-Substituted Pyrazolo[4,5-E][1,2,4]thiadiazines

ChemInform Abstract: Synthesis and Anti‐hiv Activity Evaluation of Novel 2,4‐disubstituted 7‐Methyl‐1,1,3‐trioxo‐2,4‐dihydro‐pyrazolo[4,5‐e][1,2]thiadiazines.

ChemInform Abstract: Structure‐Based Design, Synthesis and Biological Evaluation of New N‐Carboxyphenylpyrrole Derivatives as HIV Fusion Inhibitors Targeting gp41.

4‐Aminopyrimidines As Novel HIV‐1 Inhibitors.

ChemInform Abstract: Synthesis and Anti‐hiv Activity Evaluation of 2‐(4‐(naphthalen‐2‐yl)‐1,2,3‐thiadiazol‐5‐ylthio)‐n‐acetamides As Novel Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors.

Synthesis and biological evaluation of novel 2-arylalkylthio-4-amino-6-benzyl pyrimidines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.

ChemInform Abstract: Design, Synthesis and Anti‐hiv Integrase Evaluation of 1,2,3‐triazol‐4‐yl‐substituted 1,4‐dihydro‐4‐oxo‐1,5‐naphthyridine‐3‐carboxylic Acids.

Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 7. Synthesis, Antiviral Activity, and 3D‐QSAR Investigations of Novel 6‐(1‐naphthoyl) HEPT Analogues.

Synthesis and anti-HIV activity of 4-(naphthalen-1-yl)-1,2,5-thiadiazol-3-hydroxyl derivatives.

Arylazolyl(azinyl)thioacetanilides. Part 10: design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors.

Fused Heterocyclic Compounds Bearing Bridgehead Nitrogen As Potent HIV-1 NNRTIs. Part 1: Design, Synthesis and Biological Evaluation of Novel 5,7-Disubstituted Pyrazolo[1,5-A]pyrimidine Derivatives.

Synthesis and Anti-Hiv Activity of Novel 2,4-Disubstituted-7-methyl-1,1,3-trioxo-2h,4h-pyrazolo[4,5-e][1,2,4]thiadiazine Derivatives

Design, synthesis and biological evaluation of N2,N 4-disubstituted-1,1,3-trioxo-2H,4H-pyrrolo[1,2-b][1,2,4,6] thiatriazine derivatives as HIV-1 NNRTIs

Synthesis and Biological Evaluation of 6‐substituted 5‐alkyl‐2‐(phenylaminocarbonylmethylthio)pyrimidin‐4(3h)‐ones As Potent HIV‐1 NNRTIs

Design, Synthesis and Biological Evaluations of Novel Oxindoles As HIV‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors. Part 1.

Arylazolylthioacetanilide. Part 8☆: Design, Synthesis and Biological Evaluation of Novel 2-(2-(2,4-dichlorophenyl)-2h-1,2,4-triazol-3-ylthio)-n-arylacetamides As Potent HIV-1 Inhibitors

Design, Synthesis and Biological Evaluation of 3-Benzyloxy-linked Pyrimidinylphenylamine Derivatives As Potent HIV-1 NNRTIs.

ChemInform Abstract: Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 11. Structural Modulations of Diaryltriazines with Potent Anti‐hiv Activity.

Synthesis and Anti-HIV-1 Activity Evaluation for Novel 3a,6a-Dihydro-1H-pyrrolo[3,4-c]pyrazole-4,6-dione Derivatives.